AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.120
+0.030 (2.75%)
Feb 27, 2026, 4:00 PM EST - Market closed
AEON Biopharma Employees
AEON Biopharma had 5 employees as of December 31, 2024. The number of employees decreased by 5 or -50.00% compared to the previous year.
Employees
5
Change (1Y)
-5
Growth (1Y)
-50.00%
Revenue / Employee
n/a
Profits / Employee
-$600
Market Cap
28.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5 | -5 | -50.00% |
| Dec 31, 2023 | 10 | 2 | 25.00% |
| Dec 31, 2022 | 8 | -12 | -60.00% |
| Dec 31, 2019 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Boundless Bio | 64 |
| Passage Bio | 60 |
| Evaxion | 46 |
| Senti Biosciences | 34 |
| AN2 Therapeutics | 22 |
AEON News
- 5 weeks ago - AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - GlobeNewsWire
- 2 months ago - AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - GlobeNewsWire
- 2 months ago - AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - GlobeNewsWire
- 3 months ago - AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - GlobeNewsWire
- 3 months ago - AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes - GlobeNewsWire
- 5 months ago - AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - GlobeNewsWire
- 7 months ago - AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire